In vitro thymosin effect on T lymphocytes in alcoholic liver disease
dc.contributor.author | Mutchnick, Milton G. | en_US |
dc.contributor.author | Goldstein, Allan L. | en_US |
dc.date.accessioned | 2006-04-07T17:36:35Z | |
dc.date.available | 2006-04-07T17:36:35Z | |
dc.date.issued | 1979-03 | en_US |
dc.identifier.citation | Mutchnick, Milton G., Goldstein, Allan L. (1979/03)."In vitro thymosin effect on T lymphocytes in alcoholic liver disease." Clinical Immunology and Immunopathology 12(3): 271-280. <http://hdl.handle.net/2027.42/23618> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WCK-4BMD49B-P0/2/c1b2129880ad7a4d7ad728019f2fefda | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/23618 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=313287&dopt=citation | en_US |
dc.description.abstract | The in vitro effect of thymosin fraction 5, a thymic gland extract, on thymus-dependent lymphocytes was studied in 12 patients with alcoholic hepatitis (AH) and in 18 patients with compensated alcoholic cirrhosis (CAC). The baseline number and proportion of spontaneous rosette-forming T lymphocytes were significantly reduced in AH as compared to the controls. No such decrease was seen in CAC. When the lymphocytes of patients with AH were incubated in the presence of thymosin fraction 5, the subsequent number and proportion of rosette-forming T lymphocytes showed a significant increase. There was no significant reponse to thymosin in CAC or in control subjects. There appears to be a subset of immature T lymphocytes in patients with AH that is responsive to exogenous thymic factors with subsequent activation of the capacity to form spontaneous rosettes. | en_US |
dc.format.extent | 639207 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | In vitro thymosin effect on T lymphocytes in alcoholic liver disease | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Microbiology and Immunology | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Research Service, Veterans Administration Hospital, Ann Arbor, Michigan 48105, USA; Department of Medicine, University of Michigan, Ann Arbor, Michigan 49105, USA | en_US |
dc.contributor.affiliationother | Department of Biochemistry, George Washington University Medical Center, Washington, D.C. 20037, USA | en_US |
dc.identifier.pmid | 313287 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/23618/1/0000581.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0090-1229(79)90030-8 | en_US |
dc.identifier.source | Clinical Immunology and Immunopathology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.